Literature findings confirmed that renal problems and FSGS in particular in CMT patients occur so far exclusively in association with mutations in INF2. In addition, deafness, cerebral white matter hyperintensities, and enlarged ventricles have been described in association with INF2 mutations (Appendix S1). This evidence concerns the gene INF2 and focal segmental glomerulosclerosis.